Ellis, James L.
GlaxoSmithKline (United States)
3 papers on CoChat
Most cited papers
- Verified
Sirtuin activators and inhibitors: Promises, achievements, and challenges
Dai, H., Sinclair, D. A., Ellis, J. L., & Steegborn, C. (2018) · Pharmacology & Therapeutics
Sirtuins and Resveratrol in MedicineHistone Deacetylase Inhibitors Research
Cited by 463
- Verified
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Mitchell, S. J., Bernier, M., Aon, M. A., Cortassa, S., Kim, E. Y., Fang, E. F., Palacios, H. H., Ali, A., Navas-Enamorado, I., Di Francesco, A., et al. (2018) · Cell Metabolism
Sirtuins and Resveratrol in MedicineGenetics, Aging, and Longevity in Model Organisms
Cited by 338
- Verified
The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
Miranda, M. X., van Tits, L. J., Lohmann, C., Arsiwala, T., Winnik, S., Tailleux, A., Stein, S., Gomes, A. P., Suri, V., Ellis, J. L., et al. (2015) · European Heart Journal
Cholesterol and Lipid MetabolismSirtuins and Resveratrol in Medicine
Cited by 153
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free